TARU PUBLICATIONS
COLLNET Journal of Scientometrics and Information Management cover
Open Access ·Peer-reviewed·ISSN (Online): 2168-930X·ISSN (Print): 0973-7766

WoS  JIF 2026 : 0.6 (Q3)

Powered by:Powered by

Half-Yearly Journal: Publishes research and articles on scientometrics and information management, including bibliometric analysis and quality assurance models.

Issues up to 2022 co-published with and available at:Taylor & Francis Online
EDITOR-CJSIM@tarupublications.com
Open Access Research Article

Classic articles in cervical cancer research : A bibliometric analysis

, *

* Corresponding author · click or hover a name for details

pp. 81–98Vol. 17Issue 1June 2023DOI: 10.47974/CJSIM-2022-0029XML
Published Online:
01 Jun 2023
Article type:
Research Article
Language:
EN
Article no.:
CJSIM-2022-0029
Pages:
81–98

Abstract

Background: Analyzing classic articles or research papers that received total citations of 1000 or more has helped study the evolution of research trends and identify research gaps and future directions in a particular field. This study used a bibliometric approach to analyzing classic articles in cervical cancer research. Method: Classic articles in cervical cancer research with 1,000 or more citations from the Web of Science Core Collection from publication to the end of 2020 were analyzed using bibliometric analysis. These methods determine the document types, most productive countries, institutions, and journals for classic articles in cervical cancer research. Moreover, it also determined their research impact through the years by analyzing their citation histories. Result: We documented 46 classic cervical cancer research papers published in the Web of Science from 1983 until 2019. The CA-A Cancer Journal for Clinicians and the New England Journal of Medicine were the most productive journals that published seven classic cervical cancer articles. The USA was the most productive country, with 28 classic cervical cancer articles. The International Agency for Research on Cancer in France and the American Cancer Society in the USA were the most effective and impactful institutions in cervical cancer research. Citation histories revealed that the most important and cited papers in recent years were cancer statistics that report incidence and mortality from cervical cancer worldwide. The most impactful studies include articles on HPV as a necessary cause of cervical cancer, the discovery and development of HPV vaccines to prevent cervical cancer, and the development of chemotherapy, radiotherapy, and surgical treatment for cervical cancer. Conclusion: This study showed cervical cancer research’s most productive countries, institutions, and journals. It also demonstrated the citation history of these classic articles, which showed influential studies still relevant to cervical cancer research until recently.

Keywords

References

[1] Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X. S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., Marcos-Gragera, R., Stiller, C., Azevedo E Silva, G., Chen, W. Q., Ogunbiyi, O. J., Rachet, B., Soeberg, M. J., You, H., Matsuda, T., … Miles, S. A., Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). The Lancet, 385(9972), 977-1010 (2015). https://doi.org/10.1016/S0140- 6736(14)62038-9.
[2] Bosch, F. X., Manos, M. M., Muñoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., & Shan, K. V., Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. Journal of the National Cancer Institute, 87(11),
796-802 (1995). https://doi.org/10.1093/jnci/87.11.796.
[3] Boshart, M., Gissman, L., Ikenberg, H., Kleinheinz, A., Scheurlen, W., & zur Hausen, H., A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. The EMBO Journal, 3(5), 1151-1157 (1984).
[4] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424 (2018).
https://doi.org/10.3322/caac.21492.
[5] Bray, F., Jemal, A., Grey, N., Ferlay, J., & Forman, D., Global cancer transitions according to the Human Development Index (2008-2030): A population-based study. The Lancet Oncology, 13(8), 790-801 (2012). https://doi.org/10.1016/S1470-2045(12)70211-5.
[6] Bray, F., Ren, J. S., Masuyer, E., & Ferlay, J., Global estimates of cancer prevalence for 27 sites in the adult population in 2008. International Journal of Cancer, 132(5), 1133- 1145 (2013). https://doi.org/10.1002/ijc.27711.
[7] Breugelmans, J. G., Roberge, G., Tippett, C., Durning, M., Struck, D. B., & Makanga, M. M., Scientific impact increases when researchers publish in open access and international collaboration: A bibliometric analysis on poverty-related disease papers. PLOS ONE, 13(9) (2018), e0203156. https://doi.org/10.1371/journal.pone.0203156.
[8] Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., Sy, S., Regan, C., Keane, A., Caruana, M., Nguyen, D. T. N., Smith, M. A., Laprise, J.-F., Jit, M., Alary, M., … Hutubessy, R., Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet, 395(10224), 575-590 (2020). https://doi.org/10.1016/S0140-6736(20)30068-4.
[9] Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., Liu, L., Lynch, C. F., Wentzensen, N., Jordan, R. C., Altekruse, S., Anderson, W. F., Rosenberg, P. S., & Gillison, M. L., Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology, 29(32), 4294-4301 (2011). https://doi.org/10.1200/ JCO.2011.36.4596.
[10] Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S., Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. British Journal of Cancer, 88(1), 63-69 (2003). https://doi.org/10.1038/sj.bjc.6600688.
[11] de Sanjose, S., Quint, W. G. V., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H. R., Vallejos, C. S., de Ruiz, P. A., Lima, M. A., Guimera, N., Clavero, O., Alejo, M., Llombart-Bosch, A., Cheng-Yang, C., Tatti, S. A., … Bosch, F. X., Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. The Lancet Oncology, 11(11), 1048-1056 (2010). https://doi.org/10.1016/S1470-2045(10)70230-8.
[12] Durst, M., Gissmann, L., Ikenberg, H., & Zur Hausen, H., A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proceedings of the National Academy of Sciences of the United States of America, 80(12 I), 3812-3815 (1983). https://doi.org/10.1073/pnas.80.12.3812.
[13] Eyre-Walker, A., & Stoletzki, N., The assessment of science: the relative merits of postpublication review, the impact factor, and the number of citations. PLoS Biology, 11(10) (2013), e1001675. https://doi.org/10.1371/journal.pbio.1001675.
[14] Garfield, E., 100 citation classics from the Journal of the American Medical Association. JAMA, 257(1), 52-59 (1987).
[15] Garfield, Eugene. (n.d.). What is a Citation Classic? Retrieved March 25, 2022, from http://garfield.library.upenn.edu/classics.html.
[16] Garfield, Eugene. KeyWords Plus: ISI’s Breakthrough Retrieval Method. Part 1. Expanding Your Searching Power on Current Contents on Diskette. Current Comments, 13, 295-299 (1990).
[17] Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., Roteli-Martins, C. M., Teixeira, J., Blatter, M. M., Korn, A. P., Quint, W., & Dubin, G. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial. Lancet, 364(9447), 1757-1765 (2004). https:// doi.org/10.1016/S0140-6736(04)17398-4.
[18] Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A. B., Romanowski, B., Roteli- Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G., Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus
types 16 and 18: follow-up from a randomised control trial. Lancet, 367(9518), 1247-1255 (2006). https://doi.org/10.1016/S0140-6736(06)68439-0.
[19] Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. Natural history of cervicovaginal papillomavirus infection in young women. The New England Journal of Medicine, 338(7), 423-428 (1998).
[20] Ho, Y.-S., & Kahn, M., A bibliometric study of highly cited reviews in the Science Citation Index ExpandedTM. Journal of the American Society for Information Science and Technology, 65(2), 372-385 (2013). https://doi.org/10.1002/asi.
[21] Ho, Y. S., Top-cited articles in chemical engineering in science citation index expanded: A bibliometric analysis. Chinese Journal of Chemical Engineering, 20(3), 478-488 (2012). https://doi.org/10.1016/S1004-9541(11)60209-7.
[22] Ho, Y. S., Classic articles on social work field in Social Science Citation Index: A bibliometric analysis. Scientometrics, 98(1), 137-155 (2014). https://doi.org/10.1007/ s11192-013-1014-8.
[23] Ho, Y. S., & Hartley, J., Classic articles in Psychology in the Science Citation Index Expanded: A bibliometric analysis. British Journal of Psychology (London, England : 1953), 107(4), 768-780 (2016). https://doi.org/10.1111/bjop.12163.
[24] Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P., Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Research, 56(19), 4509-4515 (1996).
[25] Hsu, Y. H. E., & Ho, Y. S., Highly cited articles in health care sciences and services field in science citation index expanded: A bibliometric analysis for 1958 – 2012. Methods of Information in Medicine, 53(6), 446-458 (2014). https://doi.org/10.3414/ME14-01-0022.
[26] Hull, R., Mbele, M., Makhafola, T., Hicks, C., Wang, S.-M., Reis, R. M., Mehrotra, R., Mkhize-Kwitshana, Z., Kibiki, G., Bates, D. O., & Dlamini, Z., Cervical cancer in low and middle-income countries. Oncology Letters, 20(3), 2058-2074 (2020). https://doi. org/10.3892/ol.2020.11754.
[27] Jallow, A. W., Lee, S.-D., & Ho, Y.-S., Classic articles in apoptotic research : A bibliometric analysis. COLLNET Journal of Scientometrics and Information Management, 15(1), 145-162 (2021). https://doi.org/10.1080/09737766.2021.1934605.
[28] Jelicic Kadic, A., Kovacevic, T., Runjic, E., Simicic Majce, A., Markic, J., Polic, B., Mestrovic, J., & Puljak, L., Research methodology used in the 50 most cited articles in the field of pediatrics: types of studies that become citation classics. BMC Medical Research Methodology, 20(1), 60 (2020). https://doi.org/10.1186/s12874-020-00940-0.
[29] Jemal, A., Bray, F., & Ferlay, J., Global Cancer Statistics: 2011. CA Cancer J Clin, 49(2), 1,33-64 (1999). https://doi.org/10.3322/caac.20107.Available.
[30] Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., Thun, M. J., Manager, M., & Re-, S., Cancer Statistics , 2005. CA Cancer J Clin, 55, 10-30 (2005).
[31] Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J., Cancer Statistics , 2006. CA Cancer J Clin, 56, 106-130 (2006).
[32] Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004). Cancer statistics, CA: A Cancer Journal for Clinicians, 54(1), 8-29 (2004). https://doi.org/10.3322/canjclin.54.1.8. 
[33] Kan Yeung, A. W., & Ho, Y. S., Identification and analysis of classic articles and sleeping beauties in neurosciences. Current Science, 114(10), 2039-2044 (2018). https://doi. org/10.18520/cs/v114/i10/2039-2044.
[34] Keys, H. M., Bundy, B. N., Stehman, F. B., Muderspach, L. I., Chafe, W. E., Suggs III, C. L., Walker, J. L., & Gersell, D., Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma. New England Journal of Medicine, 341(9), 708-708 (1999). https://doi.org/10.1056/ nejm199908263410924.
[35] Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U., A controlled trial of a human papillomavirus type 16 vaccine. The New England Journal of Medicine, 347(21), 1769-1775 (1997).
[36] Landoni, F., Maneo, A., Colombo, A., Placa, F., Milani, R., Perego, P., Favini, G., Ferri, L., & Mangioni, C., Randomised study of radical surgery versus radiotherapy for stage Ib- IIa cervical cancer. Lancet, 350(9077), 535-540 (1997). https://doi.org/10.1016/S0140-
6736(97)02250-2.
[37] Li, Z., & Ho, Y. S., Use of citation per publication as an indicator to evaluate contingent valuation research. Scientometrics, 75(1), 97-110 (2008). https://doi.org/10.1007/ s11192-007-1838-1.
[38] Long, X., Huang, J. Z., & Ho, Y. S., A historical review of classic articles in surgery field. American Journal of Surgery, 208(5), 841-849 (2014). https://doi.org/10.1016/j.amjsurg. 2014.03.016.
[39] Markowitz, L. E., & Schiller, J. T., Human Papillomavirus Vaccines. The Journal of Infectious Diseases, 224(Supplement_4), S367-S378 (2021). https://doi.org/10.1093/infdis/ jiaa621.
[40] Morris, M., Eifel, P. J., Lu, J., Grigsby, P. W., Levenback, C., Stevens, R. E., Rotman, M., Gershenson, D. M., & Mutch, D. G., Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. The New England Journal of Medicine, 340(15), 1137-1143 (1999). https://doi.org/10.1056/ NEJM199904153401501.
[41] Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V, Snijders, P. J. F., & Meijer, C. J. L. M., Epidemiologic classification of human papillomavirus types associated with cervical cancer. The New England Journal of Medicine, 348(6), 518-527 (2003). https://doi.org/10.1056/NEJMoa021641.
[42] Peters, W. A., Liu, P. Y., Barrett, R. J., Stock, R. J., Monk, B. J., Berek, J. S., Souhami, L., Grigsby, P., Gordon, W., & Alberts, D. S., Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Journal of Clinical Oncology, 18(8), 1606-1613 (2000). https://doi.org/10.1200/JCO.2000.18.8.1606.
[43] Riesenberg, D., & Lundberg, G. D., The Order of Authorship : Who’s on First ? JAMA, 264(14), 1857 (1990).
[44] Rose, P. G., Bundy, B. N., Watkins, E. B., Thigpen, J. T., Deppe, G., Maiman, M. A., Clarke-Pearson, D. L., & Insalaco, S., Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. The New England Journal of Medicine, 340(15), 1144-1153 (1999).
[45] Siegel, R. L., Miller, K. D., & Jemal, A., Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69(1), 7-34 (2019). https://doi.org/10.3322/caac.21551.
[46] Smith, D. R., Citation indexing and highly cited articles in the Australian Veterinary Journal. Australian Veterinary Journal, 86(9), 337-339 (2008). https://doi.org/https:// doi.org/10.1111/j.1751-0813.2008.00330.x.
[47] Smith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., & Clifford, G. M., Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. International Journal of Cancer, 121(3), 621-632 (2007). https://doi.org/10.1002/ijc.22527.
[48] Suk, F.-M., Wang, M.-H., & Ho, Y.-S., A historical review of classic Helicobacter pylori publications in science citation index expanded. COLLNET Journal of Scientometrics and Information Management, 13(2), 313-330 (2019). https://doi.org/10.1080/09737766.2 020.1716645.
[49] Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249
(2021). https://doi.org/https://doi.org/10.3322/caac.21660.
[50] Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A., Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65(2), 87-108 (2015). https://doi.org/10.3322/caac.21262.
[51] Villa, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., Skjeldestad, F. E., Olsson, S. E., Steinwall, M., Brown, D. R., Kurman, R. J., Ronnett, B. M., Stoler, M. H., Ferenczy, A., Harper, D. M., … Barr, E. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncology, 6(5), 271-278 (2005). https://doi.org/10.1016/S1470-2045(05)70101-7.
[52] Walboomers, J., Jacobs, M., Manos, M., Bosch, F., Kummer, J., Shah, K., Snijders, Peter, J. F., Peto, J., Meijer, C. J. . L., & Munoz, N., Human Papillomavirus Is a Necessary Cause. Journal of Pathology, 189(May), 12-19 (1999).
[53] Wang, M. H., Fu, H. Z., & Ho, Y. S., Comparison of universities’ scientific performance using bibliometric indicators. Malaysian Journal of Library and Information Science, 16(2), 1-19 (2011).
[54] Whitney, C. W., Sause, W., Bundy, B. N., Malfetano, J. H., Hannigan, E. V, Fowler, W. C. J., Clarke-Pearson, D. L., & Liao, S. Y., Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma
of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 17(5), 1339-1348 (1999). https://doi. org/10.1200/JCO.1999.17.5.1339.
[55] Zhang, X., Zeng, Q., Cai, W., & Ruan, W., Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019. BMC Public Health, 21(1), 894 (2021). https://doi.org/10.1186/s12889-021-10907-5.
[56] Zhao, M., Wu, Q., Hao, Y., Hu, J., Gao, Y., Zhou, S., & Han, L., Global, regional, and national burden of cervical cancer for 195 countries and territories, 2007–2017: findings from the Global Burden of Disease Study 2017. BMC Women’s Health, 21(1), 419 (2021).
https://doi.org/10.1186/s12905-021-01571-3.

Views: 408Downloads: 79Citations: 3